Clinical Evaluation of Safety and Tolerability of KDR2-2 Eye Drops in Healthy Volunteers With Pharmacokinetic Assessment
Clinical trial NCT04620109 · UNKNOWN
Trial details
- NCT number
- NCT04620109
- Sponsor
- Guangzhou HuiBoRui Biological Pharmaceutical Technology Co. Ltd
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-26
- Primary completion
- 2021-03-31
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.